Self-Enhanced Electrochemiluminescence Nanorods of Tris(bipyridine) Ruthenium(II) Derivative and Its Sensing Application for Detection of N-Acetyl-β-d-glucosaminidase.
Abstract
A self-enhanced electrochemiluminescence (ECL) reagent, synthesized by covalently linking bis(2,2'-bipyridyl)(4'-methyl-[2,2']bipyridinyl-4-carboxylicacid) ruthenium(II) (Ru(bpy)2(mcbpy)(2+)) with tris(3-aminopropyl)amine (TAPA), has been chosen as precursor to prepare nanorods ([Ru(bpy)2(mcbpy)(2+)-TAPA]NRs) with high luminous efficiency via a solvent-evaporation-induced self-assembly procedure. Due to the shorter electron-transfer path and less energy loss, the intramolecular reaction between the luminescent Ru(bpy)2(mcbpy)(2+) and coreactive tertiary amine group in TAPA has shown improved luminous efficiency compared with the common intermolecular ECL reactions. Moreover, using the electrochemiluminescent Ru(II)-based complex as precursor to directly prepare a nanostructure with high electro-active surface area is a more effective and convenient method for enhancing the immobilized amount of Ru(II)-based complex in the construction of biosensors compared with the traditional immobilized methods. Meanwhile, the obtained nanorods could be further functionalized easily, owing to their positive electrical property and the amino group on the surface. Here, Pt nanoparticles functionalized [Ru(bpy)2(mcbpy)(2+)-TAPA]NRs are used to ...Continue Reading
References
Citations
Electrochemical Biosensors for the Analysis of Breast Cancer Biomarkers: From Design to Application.
Related Concepts
Related Feeds
Biosensor Development & Applications
Biosensor development and applications describe recent progress in biosensor development and their applications in the field of antibiotics and metabolic engineering. Discover the latest research on biosensor development and applications in this feed.
Biosensors for Cancer Detection
Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.